Roche vs Viking Therapeutics: Revenue Comparison
Roche (RHHBY) and Viking Therapeutics (VKTX) are peers in GLP-1. Roche reported revenue of $34.3B as of Q4 2025, compared with $0 for Viking Therapeutics. Roche leads on revenue.
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q4 2025: Roche 17.1305, Viking Therapeutics 0.
* Roche reports semi-annually. Values are evenly split across both quarters within each half.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Roche, Viking Therapeutics.| Metric | Roche | Viking Therapeutics |
|---|---|---|
| Market Cap | - | - |
| Revenue | $34.26B | $0 |
| Cost of Revenue | $9.68B | $0 |
| Gross Profit | $24.58B | $0 |
| Operating Income | $7.96B | $-164.00M |
| Net Income | $6.13B | $-158.00M |
| R&D Expense | $7.48B | $150.00M |
| Earnings Per Share | $0.95 | -$1.37 |
| Gross Margin | 71.7% | - |
| Operating Margin | 23.2% | - |
| Net Profit Margin | 17.9% | - |
| Free Cash Flow | $10.67B | $-114.00M |
| Cumulative Free Cash Flow | $299.34B | $-747.00M |
| Operating Cash Flow | $13.12B | $-114.00M |
| Cash & Equivalents | $6.32B | $118.00M |